- Study: Probiotic in first three months of life reduces incidence of gastrointestinal disorders
- Study finds probiotic strain Cardioviva helps reduce cholesterol
- Nordic Naturals launches allergen-free probiotic
- Pure Encapsulations launches new probiotic product
- At least 23,000 die from antibiotic-resistant infections each year, CDC finds
STOCKHOLM A new study now available online in the journal Pediatrics supported earlier clinical research about the benefits of a specific probiotic strain on colic symptoms in infants, BioGaia recently announced.
In the new study, infants supplemented with Lactobacillus reuteri Protectis showed a significant reduction in crying time. After one week of supplementation, the reduction in crying time was 74% in the L. reuteri Protectis group, compared with 38% in the placebo group.
The primary outcome was a reduction in average crying time to less than three hours per day, which is the limit of colic, within three weeks.
"These results are in line with previous studies on colics and confirm the benefit of L. reuteri in colicky infants," stated Francesco Savino, department of pediatrics at Regina Margherita Children’s Hospital, University of Turin, Italy.